Announcements Trials
Browse Landscape

Status

Unknown 1

Sponsor Class

OTHER 1NIH 1

Study Type

Observational 1

Sponsor

Cancer Type

Other solid neoplasm 1Dermatologic 1Breast 1

Conditions

Melanoma, Cutaneous Malignant 1Melanoma 1

Interventions

aldesleukin 69Cyclophosphamide 50fludarabine phosphate 36fludarabine 30Interleukin-2 27incomplete Freund's adjuvant 22Ipilimumab 20Biopsy 20Specimen Handling 19Magnetic Resonance Spectroscopy 19MART-1 Antigen 15CTLA-4 Antigen 15sargramostim 14Nivolumab 13Filgrastim 13montanide ISA 51 12Sorafenib 12Interferon-alpha 11pembrolizumab 10trametinib 9Temozolomide 9Bevacizumab 9dabrafenib 8temsirolimus 7Sirolimus 7Gene Expression Profiling 7tanespimycin 6Paclitaxel 6Dacarbazine 6Cisplatin 6

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
NIH × Genetic Testing × Dermatologic × Clear all
NCT00450593 2013-08-12

Identifying Gene Mutations in Patients With Melanoma and in Families With a History of Hereditary Melanoma

National Cancer Institute (NCI)

Unknown
5,000 enrolled
Dermatologic

Melanoma, Cutaneous Malignant, Melanoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡